Regeneron #2066 (COVID)

A Covid-19 Clinical Trial Assessing the Safety, Tolerability , and Efficacy of Anti-Spike (s) SARS-COV-2 Monoclconal Antibodies for the Treatment of Hospitalized Patients with Covid-19.

For more information on this clinical trail Click Here.